1. UK Interoperability
Jeremy Goff
© Copyright KLAS 2016

2. Interoperability in the U.S.
KLAS Overview
Interoperability in the U.S.
UK Interoperability Study
Join The Effort
© Copyright KLAS 2016

3. WHO IS KLAS?
© Copyright KLAS 2016

4. KLAS Influence
3,100
Healthcare customer executives (VP & C-Level) who actively participate by sharing their experience and benefit from accessing KLAS data/reports.
KLAS is entirely dedicated to improving healthcare, including the worldwide provider market, payer market, and helping vendors perform better for their clients.
4,500
Healthcare organizations worldwide represented in the KLAS data through the participation of their employees each year who share their voice/experience.
25,000+
Interviews conducted each year. 90%+ are person-to-person interviews with current customers.
750
Healthcare IT products and services measured by KLAS.
200
Vendors measured and highlighted in KLAS Reports.
27,839
Downloads of KLAS specialty reports published last year by healthcare customers. Average of healthcare customer downloads per report.
15,000
Clinical End Users to date through 2017 participating in usability studies
Research focus is on the customer experience.
Vendors receive guidance.
KLAS insights assist organizations.
© Copyright KLAS 2016

5. United Kingdom
Saudi Arabia
United Kingdom
Australia
CIO
United Kingdom
Brazil
Germany
Australia
Richard Corbridge

6. INTEROPERABILITY IN THE U.S.
© Copyright KLAS 2016

7. Interoperability – Why does it matter?
© Copyright KLAS 2016

8. Engaging Stakeholders
“No Progress without Measurement”
Engaging Stakeholders
© Copyright KLAS 2016

9. What is Interoperability?
© Copyright KLAS 2016

10. US Interoperability Round 4
What we are learning from round 3 to 4 of Interoperability research in the US
30%
2016
2017
25%
athenahealth
GE Healthcare
20%
Greenway
Allscripts
Provider Interop Success Rate
15%
NextGen Healthcare
Epic
Greenway
athenahealth
MEDITECH
10%
Epic
Cerner
GE Healthcare
Allscripts
05%
McKesson
Cerner
eClinicalWorks
MEDITECH
eClinicalWorks
NextGen Healthcare
McKesson
00%
3.0
4.0
5.0
6.0
7.0
8.0
9.0
Satisfaction with Interoperability Support for Different EMR
© Copyright KLAS 2017

11. US Interoperability Round 4
What we are learning from round 3 to 4 of Interoperability research in the US
100%
Provider Interop Success Rate
Satisfaction with Interoperability Support for Different EMR
© Copyright KLAS 2017

12. The Details are in the Data
© Copyright KLAS 2016

13. UK INTEROPERABILITY
© Copyright KLAS 2016

14. UK Interoperability Round 1- (Very Early Data)
Who are the early participants?
ROLES
CARE SETTINGS REPRESENTED
EARLY DATA
Actively Sharing Clinical Data?
© Copyright KLAS 2017

15. UK Interoperability Round 1- (Very Early Data)
Supplier Strengths/Weaknesses: Rate your supplier in the following areas:
(Rating: 1= Extremely Weak, 9= Extremely Strong)
EARLY DATA
© Copyright KLAS 2017

16. UK Interoperability Round 1- (Very Early Data)
© Copyright KLAS 2017

17. Major Barriers to Interoperability- (Very Early Data)
What are the industry gaps?
“Technical skills within the NHS are hard to come by”
“Clear and consistent messaging for suppliers”
“Lack of a clear path when it comes to social care.”
“Funds and resources to pursue interoperability”
“Clinician buy-in to sharing & resolving liability concerns”
EARLY DATA
What are the supplier barriers?
“Some EPR solutions are not mature enough”
“Vendor costs are prohibitive”
“Suppliers do put barriers up – wasting resources”
“Technically challenging to link systems”
© Copyright KLAS 2017

18. JOIN THE EFFORT
© Copyright KLAS 2016